✦ LIBER ✦

FURTHER STUDIES ON CSF PROTEINS IN PATIENTS WITH TUMOUR IN THE CENTRAL NERVOUS SYSTEM : A Summary

✍ Scribed by Erland Svennilson

Book ID: 114779396
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 75 KB
Volume: 41
Category: Article
ISSN: 0001-6314
DOI: 10.1111/j.1600-0404.1965.tb01868.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Further studies on glutamate antagonists

Further studies on glutamate antagonists in the central nervous system

✍ Bailey, P.A.; Phillis, J.W.; Sastry, B.S.R. 📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Changes in lactate dehydrogenase isoenzy

Changes in lactate dehydrogenase isoenzyme patterns in patients with tumours of the central nervous system

✍ L. Rabow; K. Kristensson 📂 Article 📅 1977 🏛 Springer Vienna 🌐 English ⚖ 760 KB

Further Studies on the Specificity of Pr

Further Studies on the Specificity of Proglumide as a Selective Cholecystokinin Antagonist in the Central Nervous System

✍ B. S. BUNNEY; L. A. CHIODO; A. S. FREEMAN 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

Further studies on catecholamine synthes

Further studies on catecholamine synthesis in the spontaneously hypertensive rat: Catecholamine synthesis in the central nervous system

✍ Hirohiko Yamabe; Wybren De Jong; Walter Lovenberg 📂 Article 📅 1973 🏛 Elsevier Science 🌐 English ⚖ 558 KB

The distribution of [3H]-dibromodulcitol

The distribution of [3H]-dibromodulcitol in the central nervous system of patients with brain tumour

✍ Csetényi, J.; Áfra, D.; Kerpel-Fronius, S.; Horváth, I.P.; Institoris, L.; Eckha 📂 Article 📅 1983 🏛 Elsevier Science ⚖ 443 KB

Cell-mediated immunity and blocking fact

Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system

✍ S. Kumar; G. Taylor; J. K. Steward; M. A. Waghe; P. Morris-Jones 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 893 KB

## Abstract Lymphocytotoxicity studies were carried out in both the autochthonous and allogeneic situations in nine astrocytomas, seven medulloblastomas and two ependy‐momas. Tumour type‐specific lymphocytotoxicity was demonstrated. The degree of lymphocyte‐mediated tumour‐cell killing did not decr